Change in age distribution of COVID-19 deaths with the introduction of COVID-19 vaccination release_4rsdu555cjhopoibkkykp6pt2y

by Roberta Pastorino, Angelo Maria Pezzullo, Leonardo Villani, Francesco Andrea Causio, Cathrine Axfors, Despina G. Contopoulos-Ioannidis, Stefania Boccia, John Ioannidis

Published in Environmental Research by Elsevier BV.

2021   p112342


Most countries initially deployed COVID-19 vaccines preferentially in elderly populations. We aimed to evaluate whether population-level vaccine effectiveness is heralded by an increase in the relative proportion of deaths among non-elderly populations that were less covered by vaccination programs. We collected data from 40 countries on age-stratified COVID-19 deaths during the vaccination period (1/14/2021-5/31/2021) and two control periods (entire pre-vaccination period and excluding the first wave). We meta-analyzed the proportion of deaths in different age groups in vaccination versus control periods in countries with low vaccination rates; (2) countries with age-independent vaccination policies; and (3) countries with standard age-dependent vaccination policies. Countries that prioritized vaccination among older people saw an increasing share of deaths among 0-69 year old people in the vaccination versus the two control periods (summary proportion ratio 1.32 [95 CI% 1.24-1.41] and 1.35 [95 CI% 1.26-1.44)]. No such change was seen on average in countries with age-independent vaccination policies (1.05 [95 CI% 0.78-1.41 and 0.97 [95 CI% 0.95-1.00], respectively) and limited vaccination (0.93 [95 CI% 0.85-1.01] and 0.95 [95 CI% 0.87-1.03], respectively). Proportion ratios were associated with the difference of vaccination rates in elderly versus non-elderly people. No significant changes occurred in the share of deaths in age 0-49 among all 0-69 deaths in the vaccination versus pre-vaccination periods. The substantial shift in the age distribution of COVID-19 deaths in countries that rapidly implemented vaccination predominantly among elderly provides evidence for the population level-effectiveness of COVID-19 vaccination and a favorable evolution of the pandemic towards endemicity with fewer elderly deaths.
In text/plain format

Archived Files and Locations

application/pdf  4.0 MB
file_fmfq3dxcjnfgrndoyvbzspp7im (web) (webarchive)
Read Archived PDF
Preserved and Accessible
Type  article-journal
Stage   published
Date   2021-11-05
Language   en ?
Container Metadata
Not in DOAJ
In Keepers Registry
ISSN-L:  0013-9351
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: 101d1936-f83b-4f2b-b064-c7d3a7c13453